215 RECISTscore is associated with increased time to death or recurrence in patients undergoing radical radiotherapy for stage 3 non-small cell lung cancer

Lung Cancer 2026

View at publisher

Authors: Emily Jane Hughes, Conor McKeag, Gordon W. Cowell, John D. Maclay

DOI: 10.1016/j.lungcan.2026.109163

Cited by: 0

Fields of Study & Subjects

Lung Cancer Diagnosis and Treatment Radiomics and Machine Learning in Medical Imaging Lung Cancer Treatments and Mutations